AFP avatar

AFP

AFP text, photo, graphic, audio or video material shall not be published, broadcast, rewritten for broadcast or publication or redistributed directly or indirectly in any medium. AFP news material may not be stored in whole or in part in a computer or otherwise except for personal and non-commercial use. AFP will not be held liable for any delays, inaccuracies, errors or omissions in any AFP news material or in transmission or delivery of all or any part thereof or for any damages whatsoever. As a newswire service, AFP does not obtain releases from subjects, individuals, groups or entities contained in its photographs, videos, graphics or quoted in its texts. Further, no clearance is obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP material. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP material.

18957 articles published since 08 Mar 2022

Author's articles

Renault names Provost CEO after De Meo exit
Renault names Provost CEO after De Meo exit
Economy

French auto giant Renault said Wednesday that Francois Provost, currently in charge of procurement, would take over as chief executive following Luca de Meo's departure in June. Procurement director Prevost, 57, has been with Renault for 23 years and was one of De Meo's closest advisors, in particular for his "Renaultution" strategic plan.

Aston Martin pares outlook as US tariffs weigh
Aston Martin pares outlook as US tariffs weigh
Economy

British luxury carmaker Aston Martin Lagonda on Wednesday revised down its full-year outlook as US President Donald Trump's tariffs weigh on operations. Automakers have been among the companies hit hardest by Trump's tariffs onslaught as he tries to bring auto production back to the United States.

GSK reports improved outlook despite US drug tariffs
GSK reports improved outlook despite US drug tariffs
Economy

British pharmaceutical group GlaxoSmithKline said Wednesday that its annual performance should be better than expected, despite US tariffs, after sales of its cancer drugs jumped in the second quarter. Group sales increased one percent to £8 billion, helped by a 36 percent increase in cancer treatments that offset falls for other drugs, including for influenza.

Hermes confirms outlook for rising sales in 2025
Hermes confirms outlook for rising sales in 2025
Economy

French luxury group Hermes confirmed Wednesday its outlook for full-year sales growth as it turned rising revenue for all parts of the world in the first half despite global economic uncertainty. "In the medium-term, despite the economic, geopolitical and monetary uncertainties around the world, the group confirms an ambitious goal for revenue growth at constant exchange rates," it said.

Latest

Trending

Top stories

Page was generated in 1.0390710830688